Hypoxic conditions confer chemoresistance to crizotinib but not to imatinib in chronic myeloid leukemia cells Lena Avinery; Danielle Regev; Hazem Khamaisi; Jacob Gopas; Jamal Mahajna;

TREATMENT-FREE REMISSION IN CHRONIC MYELOID LEUKEMIA: CURRENT EVIDENCE, PREDICTORS, AND FUTURE DIRECTIONS Yunus Çatma;

Epidemiological characterization of chronic myeloid leukaemia patients at an oncologic centre: A retrospective observational study Ana Maria Meireles; Rita Calisto; Maria José Bento; Pedro Martinho Gouveia; Susana Bizarro; Manuel Teixeira; Cláudia Moreira; Ana Espírito Santo; Mário Mariz;